Talk:Hepatocyte

This is the talk page for discussing improvements to the Hepatocyte article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent.

Physiology Mid‑importance

	This article is within the scope of WikiProject Physiology, a collaborative effort to improve the coverage of Physiology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PhysiologyWikipedia:WikiProject PhysiologyTemplate:WikiProject PhysiologyPhysiology articles
Mid	This article has been rated as Mid-importance on the importance scale.
	This article has been classified as relating to the physiology of cells.

Anatomy: Microanatomy Mid‑importance

	This article is within the scope of WikiProject Anatomy, a collaborative effort to improve the coverage of Anatomy on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.AnatomyWikipedia:WikiProject AnatomyTemplate:WikiProject AnatomyAnatomy articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article has been classified as relating to microanatomy.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Hepatocyte.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
Edits made by the below user(s) were last checked for neutrality on March 2016 Tagishsimon.

Dcbennett2 (talk · contribs) has been paid by SciWri Services on behalf of Cellectis. Their editing has included contributions to this article. Paid editing declared here

Tip: Anchors are case-sensitive in most browsers.

This article links to one or more target anchors that no longer exist.

[[Regeneration (biology)#Regeneration of human liver|regenerate]] The anchor (#Regeneration of human liver) has been deleted by other users before.

Please help fix the broken anchors. You can remove this template after fixing the problems. | Reporting errors

Untitled[edit]

Isolated hepatocytes represent one of the most useful in vitro experimental systems for drug discovery and development. As the liver is the major organ for drug metabolism and often a target of drug toxicity, isolated hepatocytes can be used for the evaluation of metabolic stability, metabolite identification, pharmacokinetic drug-drug interactions, and drug toxicity. Our laboratory (Li, AP et al) has over 25 years of experience in hepatocyte isolation, culturing and cryopreservation. Our most recent accomplishment is the cryopreservation of human hepatocytes to retain high viability (routinely over 90% based on trypan blue exclucion) and attachment efficiency (over 50% of our cryopreserved lots can attach and form confluent monolayer cultures after thawing). We are now working to extend this cryopreservation technique to animal hepatocytes (we will start with rat hepatocytes). I would like to welcome discussion on isolated hepatocytes from the public, especially on new science, techniques and applications.Lialbertpakhung 11:59, 24 February 2007 (UTC)[reply]

Size of a hepatocyte[edit]

An IP editor was caught by the edit filter when trying to ask this question, so I am adding it on their behalf: How big (in nm) is a hepatocyte? The article doesn't say... perhaps it should? 28bytes (talk) 14:33, 5 April 2011 (UTC)[reply]

Size of a hepatocyte (continued)[edit]

My number sense was triggered by the figures in this section. A cube with volume of 3.4 x 10-9 cm3 would have a side of about 13 μm (not 20-30). Conversely, a cube of side between 20 and 30 μm would have volume between 8 and 27 x 10-9 cm3, not 3.4. Does the reference provide both of these figures? The discrepancy might be explained if the hepatocyte is not a strict cube, but maybe has projections like a shark's egg case. Alternatively, the cell may have a thick wall, and the figure given is for interior volume. Neither of these ideas is supported by an image search for “hepatocyte”. Mathyeti (talk) 03:47, 14 September 2017 (UTC)[reply]

Text removal[edit]

I've removed the following text, introduced by a user with COI and thought to point to the work of scientists employed by the compan, Cellectis, employing the user. See Wikipedia:Conflict_of_interest/Noticeboard#Cellectis. Please feel free to re-insert if in your judgement the article needs the removed information, and the references are appropriate. thanks. --Tagishsimon (talk) 02:23, 20 March 2016 (UTC)[reply]

Hepatocytes can also be derived from pluripotent stem cells; the use of stem cell-derived hepatocytes has shown some promise as a model for drug-induced liver toxicity, but further research is required^[1]^[2].

References

^ Sartipy, Peter; Björquist, Petter (2011-05-01). "Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment". Stem Cells (Dayton, Ohio). 29 (5): 744–748. doi:10.1002/stem.631. ISSN 1549-4918. PMID 21433222.
^ Mandenius, Carl-Fredrik; Andersson, Tommy B.; Alves, Paula M.; Batzl-Hartmann, Christine; Björquist, Petter; Carrondo, Manuel J. T.; Chesne, Christophe; Coecke, Sandra; Edsbagge, Josefina (2011-05-01). "Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines - a report on the Vitrocellomics EU-project". Alternatives to laboratory animals: ATLA. 39 (2): 147–171. ISSN 0261-1929. PMID 21639679.

[1] Sartipy, Peter; Björquist, Petter (2011-05-01). "Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment". Stem Cells (Dayton, Ohio). 29 (5): 744–748. doi:10.1002/stem.631. ISSN 1549-4918. PMID 21433222.

[2] Mandenius, Carl-Fredrik; Andersson, Tommy B.; Alves, Paula M.; Batzl-Hartmann, Christine; Björquist, Petter; Carrondo, Manuel J. T.; Chesne, Christophe; Coecke, Sandra; Edsbagge, Josefina (2011-05-01). "Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines - a report on the Vitrocellomics EU-project". Alternatives to laboratory animals: ATLA. 39 (2): 147–171. ISSN 0261-1929. PMID 21639679.

[1]

[2]